Intercept Pharmaceuticals, Inc. et al v. Zenara Pharma Private Limited
Plaintiff: Intercept Pharmaceuticals, Inc. and Intercept Pharma Europe Limited
Defendant: Zenara Pharma Private Limited
Case Number: 1:2022cv01215
Filed: September 16, 2022
Court: US District Court for the District of Delaware
Presiding Judge: Maryellen Noreika
Nature of Suit: Patent - Abbreviated New Drug Application(ANDA)
Cause of Action: 35 U.S.C. ยง 271 Patent Infringement
Jury Demanded By: None
Docket Report

This docket was last retrieved on September 22, 2022. A more recent docket listing may be available from PACER.

Date Filed Document Text
September 22, 2022 Filing 7 WAIVER OF SERVICE returned executed by Intercept Pharmaceuticals, Inc., Intercept Pharma Europe Limited: For Zenara Pharma Private Limited waiver sent on 9/22/2022, answer due 11/21/2022. (Tigan, Jeremy)
September 21, 2022 Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. (rjb)
September 16, 2022 Filing 6 Summons Issued as to Zenara Pharma Private Limited on 9/16/2022. (mpb)
September 16, 2022 Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Intercept Pharmaceuticals, Inc. for Intercept Pharma Europe Limited; filed by Intercept Pharma Europe Limited, Intercept Pharmaceuticals, Inc.. (mpb)
September 16, 2022 Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,238,673 B2 ;10,047,117 B2 ;10,052,337 B2 ;10,174,073 B2 ;10,751,349 B2 ;10,758,549 B2. (mpb)
September 16, 2022 Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 08/08/2022. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 2/8/2025. (mpb)
September 16, 2022 Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mpb)
September 16, 2022 Filing 1 COMPLAINT filed against Zenara Pharma Private Limited ( Filing fee $ 402, receipt number ADEDC-3961408.) - filed by Intercept Pharmaceuticals, Inc., Intercept Pharma Europe Limited. (Attachments: #1 Exhibit A-G, #2 Civil Cover Sheet)(mpb)

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the Delaware District Court's Electronic Court Filings (ECF) System

Search for this case: Intercept Pharmaceuticals, Inc. et al v. Zenara Pharma Private Limited
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Intercept Pharmaceuticals, Inc.
Represented By: Jack B. Blumenfeld
Represented By: Jeremy A. Tigan
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Intercept Pharma Europe Limited
Represented By: Jack B. Blumenfeld
Represented By: Jeremy A. Tigan
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Zenara Pharma Private Limited
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?